Transaction · 0001628280-26-070383

Burnett Patrick

Burnett Patrick, EVP, CMO, reported an open-market or private sale at Arcutis Biotherapeutics, Inc. involving 943.000000 shares for an estimated $30047.19. Reported holdings after the transaction were 116649.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SEVP, CMO
ARQTArcutis Biotherapeutics, Inc.
Trade date
Nov 02, 2026
Filing date
Nov 04, 2026
View on SEC Insider profile
Disclosed value-$30.0kShares × reported price
Shares traded943$31.86 per share
Holdings after116kDirect
% of reported position traded0.8%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 117,592 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ARQT price since this filing

Daily closing prices, with the filing date and available return windows
ARQT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -26.1%1w ago -6.6%1d ago -5.8%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001628280-26-070383
Common Stock
Transaction date
Nov 02, 2026
Filed Nov 04, 2026, 11:38 PM · 2d delay
Shares
943 sh
$31.86 per share
Estimated value
-$30.0k
Computed from shares × price
Holdings after
116,649 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.

  2. F2

    The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $31.57 to $32.23, inclusive. The Reporting Person hereby

  3. undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respec…

  4. price within the range set forth in this footnote.

Original filing · 0001628280-26-070383
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ARQT